Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bausch & Lomb Envisions European Synergies In $228 Mil. Chauvin Deal

This article was originally published in The Gray Sheet

Executive Summary

Bausch & Lomb's $228 mil. acquisition of the French ophthalmic pharmaceutical maker Groupe Chauvin includes 90 sales reps with which to expand the European distribution channels for the firm's developmental Envision TD technology for the delivery of drugs to the back of the eye.
Advertisement

Related Content

B&L Looks To Zyoptix, Eyetracking System to Boost Refractive Market Share
B&L Looks To Zyoptix, Eyetracking System to Boost Refractive Market Share
Ciba Vision Merger Expands Wesley Jessen Specialty Lens Reach Worldwide
B&L Makes "Final" Proposal For WJ's Hand, Forecasts Technolas Revenues
B&L Makes "Final" Proposal For WJ's Hand, Forecasts Technolas Revenues
Advertisement
UsernamePublicRestriction

Register

MT013659

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel